These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 23907717)
21. Cost of illness and its predictors for Parkinson's disease in Germany. Spottke AE; Reuter M; Machat O; Bornschein B; von Campenhausen S; Berger K; Koehne-Volland R; Rieke J; Simonow A; Brandstaedter D; Siebert U; Oertel WH; Ulm G; Dodel R Pharmacoeconomics; 2005; 23(8):817-36. PubMed ID: 16097843 [TBL] [Abstract][Full Text] [Related]
22. The direct and indirect costs among U.S. privately insured employees with hypogonadism. Kaltenboeck A; Foster S; Ivanova J; Diener M; Bergman R; Birnbaum H; Kinchen K; Swindle R J Sex Med; 2012 Sep; 9(9):2438-47. PubMed ID: 22738380 [TBL] [Abstract][Full Text] [Related]
23. Direct medical costs associated with Parkinson's disease: a population-based study. Leibson CL; Long KH; Maraganore DM; Bower JH; Ransom JE; O'Brien PC; Rocca WA Mov Disord; 2006 Nov; 21(11):1864-71. PubMed ID: 16977632 [TBL] [Abstract][Full Text] [Related]
24. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population. Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096 [TBL] [Abstract][Full Text] [Related]
25. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database. Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008 [TBL] [Abstract][Full Text] [Related]
26. Economic burden and co-morbidities of atrial fibrillation in a privately insured population. Wu EQ; Birnbaum HG; Mareva M; Tuttle E; Castor AR; Jackman W; Ruskin J Curr Med Res Opin; 2005 Oct; 21(10):1693-9. PubMed ID: 16238910 [TBL] [Abstract][Full Text] [Related]
27. Economic burden of sarcoidosis in a commercially-insured population in the United States. Rice JB; White A; Lopez A; Conway A; Wagh A; Nelson WW; Philbin M; Wan GJ J Med Econ; 2017 Oct; 20(10):1048-1055. PubMed ID: 28678623 [TBL] [Abstract][Full Text] [Related]
29. Costs of Parkinson's disease in eastern Europe: a Czech cohort study. Winter Y; von Campenhausen S; Brozova H; Skoupa J; Reese JP; Bötzel K; Eggert K; Oertel WH; Dodel R; Ruzicka E Parkinsonism Relat Disord; 2010 Jan; 16(1):51-6. PubMed ID: 19665915 [TBL] [Abstract][Full Text] [Related]
30. Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas. Fu S; Lairson DR; Chan W; Wu CF; Ramondetta L Gynecol Oncol; 2018 Feb; 148(2):342-348. PubMed ID: 29274828 [TBL] [Abstract][Full Text] [Related]
31. Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States. Soliman AM; Surrey E; Bonafede M; Nelson JK; Castelli-Haley J Adv Ther; 2018 Mar; 35(3):408-423. PubMed ID: 29450864 [TBL] [Abstract][Full Text] [Related]
32. The economic burden of schizophrenia in the United States in 2002. Wu EQ; Birnbaum HG; Shi L; Ball DE; Kessler RC; Moulis M; Aggarwal J J Clin Psychiatry; 2005 Sep; 66(9):1122-9. PubMed ID: 16187769 [TBL] [Abstract][Full Text] [Related]
33. Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK. Weir S; Samnaliev M; Kuo TC; Tierney TS; Walleser Autiero S; Taylor RS; Schrag A Mov Disord; 2018 Jul; 33(6):974-981. PubMed ID: 29603405 [TBL] [Abstract][Full Text] [Related]
34. Direct cost of Parkinson's disease in a health system with high judicialization: evidence from Colombia. Prada SI; Pérez AM; Valderrama-Chaparro J; Molina-Echeverry MI; Orozco JL; Takeuchi Y Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):587-593. PubMed ID: 31627711 [No Abstract] [Full Text] [Related]
36. Determining initial and follow-up costs of cardiovascular events in a US managed care population. Chapman RH; Liu LZ; Girase PG; Straka RJ BMC Cardiovasc Disord; 2011 Mar; 11():11. PubMed ID: 21410963 [TBL] [Abstract][Full Text] [Related]
37. Direct Costs in Patients with Celiac Disease in the USA: A Retrospective Claims Analysis. Guandalini S; Tundia N; Thakkar R; Macaulay D; Essenmacher K; Fuldeore M Dig Dis Sci; 2016 Oct; 61(10):2823-2830. PubMed ID: 27417565 [TBL] [Abstract][Full Text] [Related]
38. Shifting to outpatient care? Mental health care use and cost under private insurance. Leslie DL; Rosenheck R Am J Psychiatry; 1999 Aug; 156(8):1250-7. PubMed ID: 10450268 [TBL] [Abstract][Full Text] [Related]
39. Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population. Pilon D; Ding Z; Muser E; Obando C; Voelker J; Manceur AM; Kinkead F; Lafeuille MH; Lefebvre P Curr Med Res Opin; 2020 Aug; 36(8):1285-1294. PubMed ID: 32427006 [No Abstract] [Full Text] [Related]
40. Wilson's Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United States. Rustgi VK; Gupta K; Tait C; Bhurwal A; Kabaria S; Catalano C; Li Y; Minacapelli CD Hepatol Commun; 2022 Feb; 6(2):389-398. PubMed ID: 34559472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]